Short-term Uresta efficacy (SURE) study: a randomized controlled trial of the Uresta continence device

Area of Science:

• Urogynecology
• Pelvic Floor Disorders
• Medical Device Efficacy

Background:

• Stress urinary incontinence (SUI) affects many women, impacting quality of life.
• Existing treatments for SUI have limitations, necessitating novel approaches.
• The Uresta intravaginal device is a potential non-surgical option for SUI management.

Purpose of the Study:

• To evaluate the short-term efficacy of the Uresta intravaginal device for treating SUI.
• To compare the Uresta device's effectiveness against a placebo using a randomized controlled trial.

Main Methods:

• A single-blind, randomized placebo-controlled trial was conducted.
• Participants with urodynamic SUI were randomized to the Uresta device or a placebo vaginal ring.
• Pad tests before and after device placement measured objective urine loss reduction.

Main Results:

• The Uresta group achieved a 50% or greater reduction in pad weight significantly more often than the placebo group (66.7% vs. 22.2%, p=0.01).
• Baseline demographics were similar between groups.
• No adverse events were reported during the study period.

Conclusions:

• The Uresta intravaginal continence device demonstrates significant short-term efficacy in reducing objective measures of urine loss in women with SUI.
• Further research is warranted to assess subjective outcomes and long-term patient satisfaction with the Uresta device.